APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

AI Medical Imaging Software for Lung Diseases

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global AI Medical Imaging Software for Lung Diseases Market Analysis and Forecast 2026-2032

Report ID 173896460225 December 2025197 pages

Choose your research edition.

Industry ResearchAI Medical Imaging Software for Lung Diseases Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Medical Imaging Software for Lung Diseases Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal AI Medical Imaging Software for Lung Diseases Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Medical Imaging Software for Lung Diseases Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Medical Imaging Software for Lung Diseases Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global AI Medical Imaging Software for Lung Diseases market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI Medical Imaging Software for Lung Diseases is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI Medical Imaging Software for Lung Diseases is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for AI Medical Imaging Software for Lung Diseases is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI Medical Imaging Software for Lung Diseases is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI Medical Imaging Software for Lung Diseases include Riverain Technologies, BioMind, Fosun Aitrox, Huiying Medical, United-Imaging, Deepwise, Shukun Technology, VoxelCloud and Infervision Medical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI Medical Imaging Software for Lung Diseases, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI Medical Imaging Software for Lung Diseases, also provides the revenue of main regions and countries. Of the upcoming market potential for AI Medical Imaging Software for Lung Diseases, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI Medical Imaging Software for Lung Diseases revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI Medical Imaging Software for Lung Diseases market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI Medical Imaging Software for Lung Diseases revenue, projected growth trends, production technology, application and end-user industry.

AI Medical Imaging Software for Lung Diseases Segment by Company

Riverain Technologies

BioMind

Fosun Aitrox

Huiying Medical

United-Imaging

Deepwise

Shukun Technology

VoxelCloud

Infervision Medical

Siemens

Yizhun Intelligent

AI Medical Imaging Software for Lung Diseases Segment by Type

Pulmonary Nodules

Pneumonia

Other

AI Medical Imaging Software for Lung Diseases Segment by Application

Hospital

Clinic

AI Medical Imaging Software for Lung Diseases Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Medical Imaging Software for Lung Diseases market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Medical Imaging Software for Lung Diseases and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Medical Imaging Software for Lung Diseases.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of AI Medical Imaging Software for Lung Diseases in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of AI Medical Imaging Software for Lung Diseases company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Medical Imaging Software for Lung Diseases revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Pulmonary Nodules Major Player Table 3. Pneumonia Major Player Table 4. Other Major Player Table 5. Global AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Player Table 7. Clinic Major Player Table 8. AI Medical Imaging Software for Lung Diseases Industry Trends Table 9. AI Medical Imaging Software for Lung Diseases Industry Drivers Table 10. AI Medical Imaging Software for Lung Diseases Industry Opportunities and Challenges Table 11. AI Medical Imaging Software for Lung Diseases Industry Restraints Table 12. Global AI Medical Imaging Software for Lung Diseases Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global AI Medical Imaging Software for Lung Diseases Market Size by Region (2021-2026) & (US$ Million) Table 14. Global AI Medical Imaging Software for Lung Diseases Market Share by Region (2021-2026) Table 15. Global AI Medical Imaging Software for Lung Diseases Market Size by Region (2027-2032) & (US$ Million) Table 16. Global AI Medical Imaging Software for Lung Diseases Market Share by Region (2027-2032) Table 17. Global AI Medical Imaging Software for Lung Diseases Revenue by Players (US$ Million) & (2021-2026) Table 18. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Players (2021-2026) Table 19. Global AI Medical Imaging Software for Lung Diseases Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global AI Medical Imaging Software for Lung Diseases Key Players Headquarters & Area Served Table 21. Global AI Medical Imaging Software for Lung Diseases Players, Product Type & Application Table 22. Global AI Medical Imaging Software for Lung Diseases Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global AI Medical Imaging Software for Lung Diseases by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global AI Medical Imaging Software for Lung Diseases Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global AI Medical Imaging Software for Lung Diseases Revenue by Type (2021-2026) & (US$ Million) Table 27. Global AI Medical Imaging Software for Lung Diseases Revenue by Type (2027-2032) & (US$ Million) Table 28. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Type (2021-2026) Table 29. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Type (2027-2032) Table 30. Global AI Medical Imaging Software for Lung Diseases Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global AI Medical Imaging Software for Lung Diseases Revenue by Application (2021-2026) & (US$ Million) Table 32. Global AI Medical Imaging Software for Lung Diseases Revenue by Application (2027-2032) & (US$ Million) Table 33. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Application (2021-2026) Table 34. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Application (2027-2032) Table 35. Riverain Technologies Company Information Table 36. Riverain Technologies Business Overview Table 37. Riverain Technologies AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Riverain Technologies AI Medical Imaging Software for Lung Diseases Product Portfolio Table 39. Riverain Technologies Recent Development Table 40. BioMind Company Information Table 41. BioMind Business Overview Table 42. BioMind AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. BioMind AI Medical Imaging Software for Lung Diseases Product Portfolio Table 44. BioMind Recent Development Table 45. Fosun Aitrox Company Information Table 46. Fosun Aitrox Business Overview Table 47. Fosun Aitrox AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Fosun Aitrox AI Medical Imaging Software for Lung Diseases Product Portfolio Table 49. Fosun Aitrox Recent Development Table 50. Huiying Medical Company Information Table 51. Huiying Medical Business Overview Table 52. Huiying Medical AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Huiying Medical AI Medical Imaging Software for Lung Diseases Product Portfolio Table 54. Huiying Medical Recent Development Table 55. United-Imaging Company Information Table 56. United-Imaging Business Overview Table 57. United-Imaging AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. United-Imaging AI Medical Imaging Software for Lung Diseases Product Portfolio Table 59. United-Imaging Recent Development Table 60. Deepwise Company Information Table 61. Deepwise Business Overview Table 62. Deepwise AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Deepwise AI Medical Imaging Software for Lung Diseases Product Portfolio Table 64. Deepwise Recent Development Table 65. Shukun Technology Company Information Table 66. Shukun Technology Business Overview Table 67. Shukun Technology AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Shukun Technology AI Medical Imaging Software for Lung Diseases Product Portfolio Table 69. Shukun Technology Recent Development Table 70. VoxelCloud Company Information Table 71. VoxelCloud Business Overview Table 72. VoxelCloud AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. VoxelCloud AI Medical Imaging Software for Lung Diseases Product Portfolio Table 74. VoxelCloud Recent Development Table 75. Infervision Medical Company Information Table 76. Infervision Medical Business Overview Table 77. Infervision Medical AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Infervision Medical AI Medical Imaging Software for Lung Diseases Product Portfolio Table 79. Infervision Medical Recent Development Table 80. Siemens Company Information Table 81. Siemens Business Overview Table 82. Siemens AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Siemens AI Medical Imaging Software for Lung Diseases Product Portfolio Table 84. Siemens Recent Development Table 85. Yizhun Intelligent Company Information Table 86. Yizhun Intelligent Business Overview Table 87. Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Product Portfolio Table 89. Yizhun Intelligent Recent Development Table 90. North America AI Medical Imaging Software for Lung Diseases Revenue by Type (2021-2026) & (US$ Million) Table 91. North America AI Medical Imaging Software for Lung Diseases Revenue by Type (2027-2032) & (US$ Million) Table 92. North America AI Medical Imaging Software for Lung Diseases Revenue by Application (2021-2026) & (US$ Million) Table 93. North America AI Medical Imaging Software for Lung Diseases Revenue by Application (2027-2032) & (US$ Million) Table 94. North America AI Medical Imaging Software for Lung Diseases Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America AI Medical Imaging Software for Lung Diseases Revenue by Country (2021-2026) & (US$ Million) Table 96. North America AI Medical Imaging Software for Lung Diseases Revenue by Country (US$ Million) & (2027-2032) Table 97. Europe AI Medical Imaging Software for Lung Diseases Revenue by Type (2021-2026) & (US$ Million) Table 98. Europe AI Medical Imaging Software for Lung Diseases Revenue by Type (2027-2032) & (US$ Million) Table 99. Europe AI Medical Imaging Software for Lung Diseases Revenue by Application (2021-2026) & (US$ Million) Table 100. Europe AI Medical Imaging Software for Lung Diseases Revenue by Application (2027-2032) & (US$ Million) Table 101. Europe AI Medical Imaging Software for Lung Diseases Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe AI Medical Imaging Software for Lung Diseases Revenue by Country (2021-2026) & (US$ Million) Table 103. Europe AI Medical Imaging Software for Lung Diseases Revenue by Country (US$ Million) & (2027-2032) Table 104. China AI Medical Imaging Software for Lung Diseases Revenue by Type (2021-2026) & (US$ Million) Table 105. China AI Medical Imaging Software for Lung Diseases Revenue by Type (2027-2032) & (US$ Million) Table 106. China AI Medical Imaging Software for Lung Diseases Revenue by Application (2021-2026) & (US$ Million) Table 107. China AI Medical Imaging Software for Lung Diseases Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia AI Medical Imaging Software for Lung Diseases Revenue by Type (2021-2026) & (US$ Million) Table 109. Asia AI Medical Imaging Software for Lung Diseases Revenue by Type (2027-2032) & (US$ Million) Table 110. Asia AI Medical Imaging Software for Lung Diseases Revenue by Application (2021-2026) & (US$ Million) Table 111. Asia AI Medical Imaging Software for Lung Diseases Revenue by Application (2027-2032) & (US$ Million) Table 112. Asia AI Medical Imaging Software for Lung Diseases Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia AI Medical Imaging Software for Lung Diseases Revenue by Region (US$ Million) & (2021-2026) Table 114. Asia AI Medical Imaging Software for Lung Diseases Revenue by Region (US$ Million) & (2027-2032) Table 115. SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Type (2021-2026) & (US$ Million) Table 116. SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Type (2027-2032) & (US$ Million) Table 117. SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Application (2021-2026) & (US$ Million) Table 118. SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Application (2027-2032) & (US$ Million) Table 119. SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Country (2021-2026) & (US$ Million) Table 121. SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Country (US$ Million) & (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. AI Medical Imaging Software for Lung Diseases Image Figure 2. Global AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Medical Imaging Software for Lung Diseases Market Size Share 2021 VS 2025 VS 2032 Figure 4. Pulmonary Nodules Image Figure 5. Pneumonia Image Figure 6. Other Image Figure 7. Global AI Medical Imaging Software for Lung Diseases Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global AI Medical Imaging Software for Lung Diseases Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Global AI Medical Imaging Software for Lung Diseases Market Size (US$ Million) & (2021-2032) Figure 12. Global AI Medical Imaging Software for Lung Diseases Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global AI Medical Imaging Software for Lung Diseases Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global AI Medical Imaging Software for Lung Diseases Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global AI Medical Imaging Software for Lung Diseases Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Type (2021-2032) Figure 19. Global AI Medical Imaging Software for Lung Diseases Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Application (2021-2032) Figure 22. North America AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America AI Medical Imaging Software for Lung Diseases Revenue Share by Type (2021-2032) Figure 24. North America AI Medical Imaging Software for Lung Diseases Revenue Share by Application (2021-2032) Figure 25. North America AI Medical Imaging Software for Lung Diseases Revenue Share by Country (2021-2032) Figure 26. United States AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe AI Medical Imaging Software for Lung Diseases Revenue Share by Type (2021-2032) Figure 31. Europe AI Medical Imaging Software for Lung Diseases Revenue Share by Application (2021-2032) Figure 32. Europe AI Medical Imaging Software for Lung Diseases Revenue Share by Country (2021-2032) Figure 33. Germany AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China AI Medical Imaging Software for Lung Diseases Revenue Share by Type (2021-2032) Figure 43. China AI Medical Imaging Software for Lung Diseases Revenue Share by Application (2021-2032) Figure 44. Asia AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia AI Medical Imaging Software for Lung Diseases Revenue Share by Type (2021-2032) Figure 46. Asia AI Medical Imaging Software for Lung Diseases Revenue Share by Application (2021-2032) Figure 47. Asia AI Medical Imaging Software for Lung Diseases Revenue Share by Region (2021-2032) Figure 48. Japan AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA AI Medical Imaging Software for Lung Diseases Revenue Share by Type (2021-2032) Figure 56. SAMEA AI Medical Imaging Software for Lung Diseases Revenue Share by Application (2021-2032) Figure 57. SAMEA AI Medical Imaging Software for Lung Diseases Revenue Share by Country (2021-2032) Figure 58. Brazil AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt AI Medical Imaging Software for Lung Diseases Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Pulmonary Nodules
  • Pneumonia
  • Other
Applications
  • Hospital
  • Clinic
Companies covered
  • Riverain Technologies
  • BioMind
  • Fosun Aitrox
  • Huiying Medical
  • United-Imaging
  • Deepwise
  • Shukun Technology
  • VoxelCloud
  • Infervision Medical
  • Siemens
  • Yizhun Intelligent

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 AI Medical Imaging Software for Lung Diseases Market by Type
  3. 1.2.1 Global AI Medical Imaging Software for Lung Diseases Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Pulmonary Nodules
  5. 1.2.3 Pneumonia
  6. 1.2.4 Other
  7. 1.3 AI Medical Imaging Software for Lung Diseases Market by Application
  8. 1.3.1 Global AI Medical Imaging Software for Lung Diseases Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 AI Medical Imaging Software for Lung Diseases Market Dynamics
  1. 2.1 AI Medical Imaging Software for Lung Diseases Industry Trends
  2. 2.2 AI Medical Imaging Software for Lung Diseases Industry Drivers
  3. 2.3 AI Medical Imaging Software for Lung Diseases Industry Opportunities and Challenges
  4. 2.4 AI Medical Imaging Software for Lung Diseases Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global AI Medical Imaging Software for Lung Diseases Market Perspective (2021-2032)
  2. 3.2 Global AI Medical Imaging Software for Lung Diseases Growth Trends by Region
  3. 3.2.1 Global AI Medical Imaging Software for Lung Diseases Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global AI Medical Imaging Software for Lung Diseases Market Size by Region (2021-2026)
  5. 3.2.3 Global AI Medical Imaging Software for Lung Diseases Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global AI Medical Imaging Software for Lung Diseases Revenue by Players
  2. 4.1.1 Global AI Medical Imaging Software for Lung Diseases Revenue by Players (2021-2026)
  3. 4.1.2 Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global AI Medical Imaging Software for Lung Diseases Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global AI Medical Imaging Software for Lung Diseases Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global AI Medical Imaging Software for Lung Diseases Key Players Headquarters & Area Served
  7. 4.4 Global AI Medical Imaging Software for Lung Diseases Players, Product Type & Application
  8. 4.5 Global AI Medical Imaging Software for Lung Diseases Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global AI Medical Imaging Software for Lung Diseases Market CR5 and HHI
  11. 4.6.3 2025 AI Medical Imaging Software for Lung Diseases Tier 1, Tier 2, and Tier 3
5 AI Medical Imaging Software for Lung Diseases Market Size by Type
  1. 5.1 Global AI Medical Imaging Software for Lung Diseases Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global AI Medical Imaging Software for Lung Diseases Revenue by Type (2021-2032)
  3. 5.3 Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Type (2021-2032)
6 AI Medical Imaging Software for Lung Diseases Market Size by Application
  1. 6.1 Global AI Medical Imaging Software for Lung Diseases Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global AI Medical Imaging Software for Lung Diseases Revenue by Application (2021-2032)
  3. 6.3 Global AI Medical Imaging Software for Lung Diseases Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Riverain Technologies
  2. 7.1.1 Riverain Technologies Company Information
  3. 7.1.2 Riverain Technologies Business Overview
  4. 7.1.3 Riverain Technologies AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Riverain Technologies AI Medical Imaging Software for Lung Diseases Product Portfolio
  6. 7.1.5 Riverain Technologies Recent Developments
  7. 7.2 BioMind
  8. 7.2.1 BioMind Company Information
  9. 7.2.2 BioMind Business Overview
  10. 7.2.3 BioMind AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2021-2026)
  11. 7.2.4 BioMind AI Medical Imaging Software for Lung Diseases Product Portfolio
  12. 7.2.5 BioMind Recent Developments
  13. 7.3 Fosun Aitrox
  14. 7.3.1 Fosun Aitrox Company Information
  15. 7.3.2 Fosun Aitrox Business Overview
  16. 7.3.3 Fosun Aitrox AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Fosun Aitrox AI Medical Imaging Software for Lung Diseases Product Portfolio
  18. 7.3.5 Fosun Aitrox Recent Developments
  19. 7.4 Huiying Medical
  20. 7.4.1 Huiying Medical Company Information
  21. 7.4.2 Huiying Medical Business Overview
  22. 7.4.3 Huiying Medical AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Huiying Medical AI Medical Imaging Software for Lung Diseases Product Portfolio
  24. 7.4.5 Huiying Medical Recent Developments
  25. 7.5 United-Imaging
  26. 7.5.1 United-Imaging Company Information
  27. 7.5.2 United-Imaging Business Overview
  28. 7.5.3 United-Imaging AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2021-2026)
  29. 7.5.4 United-Imaging AI Medical Imaging Software for Lung Diseases Product Portfolio
  30. 7.5.5 United-Imaging Recent Developments
  31. 7.6 Deepwise
  32. 7.6.1 Deepwise Company Information
  33. 7.6.2 Deepwise Business Overview
  34. 7.6.3 Deepwise AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Deepwise AI Medical Imaging Software for Lung Diseases Product Portfolio
  36. 7.6.5 Deepwise Recent Developments
  37. 7.7 Shukun Technology
  38. 7.7.1 Shukun Technology Company Information
  39. 7.7.2 Shukun Technology Business Overview
  40. 7.7.3 Shukun Technology AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Shukun Technology AI Medical Imaging Software for Lung Diseases Product Portfolio
  42. 7.7.5 Shukun Technology Recent Developments
  43. 7.8 VoxelCloud
  44. 7.8.1 VoxelCloud Company Information
  45. 7.8.2 VoxelCloud Business Overview
  46. 7.8.3 VoxelCloud AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2021-2026)
  47. 7.8.4 VoxelCloud AI Medical Imaging Software for Lung Diseases Product Portfolio
  48. 7.8.5 VoxelCloud Recent Developments
  49. 7.9 Infervision Medical
  50. 7.9.1 Infervision Medical Company Information
  51. 7.9.2 Infervision Medical Business Overview
  52. 7.9.3 Infervision Medical AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Infervision Medical AI Medical Imaging Software for Lung Diseases Product Portfolio
  54. 7.9.5 Infervision Medical Recent Developments
  55. 7.10 Siemens
  56. 7.10.1 Siemens Company Information
  57. 7.10.2 Siemens Business Overview
  58. 7.10.3 Siemens AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Siemens AI Medical Imaging Software for Lung Diseases Product Portfolio
  60. 7.10.5 Siemens Recent Developments
  61. 7.11 Yizhun Intelligent
  62. 7.11.1 Yizhun Intelligent Company Information
  63. 7.11.2 Yizhun Intelligent Business Overview
  64. 7.11.3 Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Product Portfolio
  66. 7.11.5 Yizhun Intelligent Recent Developments
8 North America
  1. 8.1 North America AI Medical Imaging Software for Lung Diseases Revenue (2021-2032)
  2. 8.2 North America AI Medical Imaging Software for Lung Diseases Revenue by Type (2021-2032)
  3. 8.2.1 North America AI Medical Imaging Software for Lung Diseases Revenue by Type (2021-2026)
  4. 8.2.2 North America AI Medical Imaging Software for Lung Diseases Revenue by Type (2027-2032)
  5. 8.3 North America AI Medical Imaging Software for Lung Diseases Revenue Share by Type (2021-2032)
  6. 8.4 North America AI Medical Imaging Software for Lung Diseases Revenue by Application (2021-2032)
  7. 8.4.1 North America AI Medical Imaging Software for Lung Diseases Revenue by Application (2021-2026)
  8. 8.4.2 North America AI Medical Imaging Software for Lung Diseases Revenue by Application (2027-2032)
  9. 8.5 North America AI Medical Imaging Software for Lung Diseases Revenue Share by Application (2021-2032)
  10. 8.6 North America AI Medical Imaging Software for Lung Diseases Revenue by Country
  11. 8.6.1 North America AI Medical Imaging Software for Lung Diseases Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America AI Medical Imaging Software for Lung Diseases Revenue by Country (2021-2026)
  13. 8.6.3 North America AI Medical Imaging Software for Lung Diseases Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe AI Medical Imaging Software for Lung Diseases Revenue (2021-2032)
  2. 9.2 Europe AI Medical Imaging Software for Lung Diseases Revenue by Type (2021-2032)
  3. 9.2.1 Europe AI Medical Imaging Software for Lung Diseases Revenue by Type (2021-2026)
  4. 9.2.2 Europe AI Medical Imaging Software for Lung Diseases Revenue by Type (2027-2032)
  5. 9.3 Europe AI Medical Imaging Software for Lung Diseases Revenue Share by Type (2021-2032)
  6. 9.4 Europe AI Medical Imaging Software for Lung Diseases Revenue by Application (2021-2032)
  7. 9.4.1 Europe AI Medical Imaging Software for Lung Diseases Revenue by Application (2021-2026)
  8. 9.4.2 Europe AI Medical Imaging Software for Lung Diseases Revenue by Application (2027-2032)
  9. 9.5 Europe AI Medical Imaging Software for Lung Diseases Revenue Share by Application (2021-2032)
  10. 9.6 Europe AI Medical Imaging Software for Lung Diseases Revenue by Country
  11. 9.6.1 Europe AI Medical Imaging Software for Lung Diseases Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe AI Medical Imaging Software for Lung Diseases Revenue by Country (2021-2026)
  13. 9.6.3 Europe AI Medical Imaging Software for Lung Diseases Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China AI Medical Imaging Software for Lung Diseases Revenue (2021-2032)
  2. 10.2 China AI Medical Imaging Software for Lung Diseases Revenue by Type (2021-2032)
  3. 10.2.1 China AI Medical Imaging Software for Lung Diseases Revenue by Type (2021-2026)
  4. 10.2.2 China AI Medical Imaging Software for Lung Diseases Revenue by Type (2027-2032)
  5. 10.3 China AI Medical Imaging Software for Lung Diseases Revenue Share by Type (2021-2032)
  6. 10.4 China AI Medical Imaging Software for Lung Diseases Revenue by Application (2021-2032)
  7. 10.4.1 China AI Medical Imaging Software for Lung Diseases Revenue by Application (2021-2026)
  8. 10.4.2 China AI Medical Imaging Software for Lung Diseases Revenue by Application (2027-2032)
  9. 10.5 China AI Medical Imaging Software for Lung Diseases Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia AI Medical Imaging Software for Lung Diseases Revenue (2021-2032)
  2. 11.2 Asia AI Medical Imaging Software for Lung Diseases Revenue by Type (2021-2032)
  3. 11.2.1 Asia AI Medical Imaging Software for Lung Diseases Revenue by Type (2021-2026)
  4. 11.2.2 Asia AI Medical Imaging Software for Lung Diseases Revenue by Type (2027-2032)
  5. 11.3 Asia AI Medical Imaging Software for Lung Diseases Revenue Share by Type (2021-2032)
  6. 11.4 Asia AI Medical Imaging Software for Lung Diseases Revenue by Application (2021-2032)
  7. 11.4.1 Asia AI Medical Imaging Software for Lung Diseases Revenue by Application (2021-2026)
  8. 11.4.2 Asia AI Medical Imaging Software for Lung Diseases Revenue by Application (2027-2032)
  9. 11.5 Asia AI Medical Imaging Software for Lung Diseases Revenue Share by Application (2021-2032)
  10. 11.6 Asia AI Medical Imaging Software for Lung Diseases Revenue by Country
  11. 11.6.1 Asia AI Medical Imaging Software for Lung Diseases Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia AI Medical Imaging Software for Lung Diseases Revenue by Country (2021-2026)
  13. 11.6.3 Asia AI Medical Imaging Software for Lung Diseases Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA AI Medical Imaging Software for Lung Diseases Revenue (2021-2032)
  2. 12.2 SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Type (2027-2032)
  5. 12.3 SAMEA AI Medical Imaging Software for Lung Diseases Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Application (2027-2032)
  9. 12.5 SAMEA AI Medical Imaging Software for Lung Diseases Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Country
  11. 12.6.1 SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA AI Medical Imaging Software for Lung Diseases Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst